Newsroom

Jan 06, 2022

Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference

View

Dec 11, 2021

Positive Clinical Results from More than 100 Patients Treated with Orca Bio’s Lead Investigational High Precision Cell Therapy Presented at 63rd ASH Annual Meeting

View

Nov 04, 2021

Orca Bio to Present New Clinical Data on Orca-T at the 63rd American Society of Hematology Annual Meeting

View

Feb 11, 2021

Orca Bio Announces Updated Orca-T Clinical Data Presented at the 2021 TCT (Transplantation & Cellular Therapy) Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR)

View

Jan 06, 2021

Orca Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

View

Dec 06, 2020

First Clinical Data From Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

View

Nov 04, 2020

Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting

View

Oct 14, 2020

Orca Bio Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Orca-T

View